ストックスクリーナーアプリを入手
0.00
100.00%
-104.91
Exact Sciences Corp (EXAS) 最新ニュース
Exact Sciences Corp. Stock (US30063P1057): Q1 2026 Earnings Release Scheduled for May 7 - AD HOC NEWS
Kevin Conroy (ABBOTT LABORATORIES: ABT) reports 131,451-share Form 3 holding - Stock Titan
Abbott Laboratories Stock (ABT) Opinions on Q1 Earnings and Exact Sciences Acquisition - Quiver Quantitative
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover - MSN
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits - MSN
Laura Friedman trades Exact Sciences for Abbott Laboratories in brokerage account - Investing.com India
Exact Sciences Corp. stock (US30063P1057): Is its cancer screening dominance strong enough to unlock - AD HOC NEWS
Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance - Investor's Business Daily
Abbott trims 2026 profit forecast on Exact deal hit, shares fall - Reuters
Q1 progress positions Abbott for accelerating growth in 2026 - Abbott
Abbott Cuts Profit Forecast After $21 Billion Deal, Shares Fall 4.6% - TradingView
Abbott cuts profit forecast in wake of Exact Sciences deal - Modern Healthcare
Abbott cuts 2026 profit forecast on Exact deal, shares fall - BioWorld News
Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag - Yahoo! Finance Canada
Earnings call transcript: Abbott Labs Q1 2026 results align with expectations - Investing.com
Abbott Laboratories Stock (ABT) Opened Down by 4.34% on Apr 16: What Investors Need To Know - TradingKey
Abbott reports Q1 earnings, completes Exact Sciences acquisition - Investing.com
Abbott lowers earnings forecast after $21B Exact Sciences buy - Yahoo Finance
Abbott results beat on medical device boost, Exact deal hits forecast - Yahoo Finance
Abbott (ABT) Q1 2026 earnings rise on adjusted basis after Exact Sciences acquisition - Stock Titan
Abbott adds Exact Sciences, expands into fast-growing cancer tests - Stock Titan
Abbott’s Exact acquisition drives med-tech M&A to $23.7B in March - BioWorld News
Abbott Verdict And Exact Sciences Deal Reshape Risk And Growth Outlook - Yahoo Finance
Exact Sciences to Participate in June Investor Conferences - Yahoo
Abbott’s $23 billion Exact Sciences deal revives diagnostics growth ambitions - S&P Global
Exact Sciences Corp. stock (US30063P1057): Why cancer screening leadership now drives investor focus - AD HOC NEWS
Exact Sciences Corp. stock (US30063P1057): Is its cancer screening push strong enough for U.S. inves - AD HOC NEWS
Exact Sciences Completes Enrollment of DeeP-C Clinical Trial for Colorectal Cancer Screening - Yahoo
EXAS Technical Analysis & Stock Price Forecast - Intellectia AI
Exact Sciences Corp. stock: Acquired by Abbott – What it means for you now - AD HOC NEWS
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Exact Sciences Stock: Is The Post-Earnings Slide A Buying Setup for 2026? - AD HOC NEWS
Select Health Care Portfolio's Exact Sciences Corp(EXAS) Holding History - GuruFocus
Exact Sciences (NASDAQ: EXAS) files Form 15 to suspend certain SEC reporting duties - Stock Titan
Exact Sciences Corp (EXK.DU) stock price, news, quote and history - Yahoo Finance UK
Excelerate Energy Stock: Leading Provider of LNG Infrastructure Faces Evolving Global Energy Demands - AD HOC NEWS
Zevenbergen Capital Investments LLC Has $30.75 Million Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
EXAS PE Ratio & Valuation, Is EXAS Overvalued - Intellectia AI
CIBRA Capital Ltd Acquires New Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Cinctive Capital Management LP's Exact Sciences Corp(EXAS) Holding History - GuruFocus
Wealth Enhancement Advisory Services LLC Buys 18,415 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Vanguard disaggregates holdings; Exact Sciences (NASDAQ: EXAS) shows 0 shares - Stock Titan
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences - Insider Monkey
Exact Sciences Corp. stock faces renewed scrutiny amid biotech sector volatility and pipeline update - AD HOC NEWS
Privia Health screening program increases colorectal cancer screening rates - MSN
Abbott (ABT) Stock Completes $21B Exact Sciences (EXAS) Acquisition - CoinCentral
Abbott closes $23 billion deal to buy Madison-based Exact Sciences - Yahoo Finance
EXAS Receives Neutral Rating from BTIG's Mark Massaro | EXAS Sto - GuruFocus
Abbott Finalizes Exact Sciences Acquisition, Expands Cancer Diagnostics - The Globe and Mail
Abbott completes Exact Sciences acquisition - MassDevice
Key facts: Abbott Buys Exact Sciences; Notes Settle $105; Nasdaq Delist - tradingview.com
Exact Sciences Corp stock delisted from Nasdaq after $21 billion Abbott acquisition completion - AD HOC NEWS
Abbott Acquires Exact Sciences to Lead Cancer Screening and Diagnostics Market - Minichart
0.37%
0.54%
大文字化:
|
ボリューム (24 時間):